Story thread · 2 reports / 2 sources
Hims & Hers Health resumed at JP Morgan at neutral on GLP-1 compounding headwinds
seekingalpha.com · 3d
First report: Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount — investing.com, 6d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.